Late Breaking Abstract - Artificial intelligence-based dec­­­ision support for HRCT stratification in fibrotic lung disease; an international study of 116 observers from 37 countries.

  • Lucio Calandriello
  • , John Mackintosh
  • , Federico Felder
  • , Aditya Agrawal
  • , Omer Alamoudi
  • , Laura Alberti
  • , Giuseppe Aquaro
  • , Juan Arenas-Jiménez
  • , Iain Au-Yong
  • , Sergey Avdeev
  • , Maurizio Balbi
  • , Bruno Baldi
  • , Andrea Yu-Lin Ban
  • , Ionela-Nicoleta Belaconi
  • , Elisabeth Bendstrup
  • , David Bennett
  • , Hans-Christian Blum
  • , Nicola Boscolo Bariga
  • , Gracijela Bozovic
  • , Marsel Broqi
  • John Bruzzi, Ivette Buendia-Roldan, Diana Calaras, Sérgio Campainha, Roberto G. Carbone, André Carvalho, Lorenzo Cereser, Gin Tsen Chai, Sachin Chaudhary, Nazia Chaudhuri, Patrick Alain Chui Wan Cheong, Wendy Cooper, Giuseppe Cutaia, Rosa D'Abronzo, Martijn D. De Kruif, Diemen Delgado-García, Sahajal Dhooria, Jesus J Diaz-Castanon, Glenn Eiger, Samantha Ellis, Rosa Estrada-Y-Martin, Yingying Fang

Research output: Contribution to journalConference articlepeer-review

Abstract

Methods: We evaluated a deep learning algorithm (DL), for classifying HRCT based on ATS/ERS/JRS/ALAT IPF guideline criteria (SOFIA), among an international group of radiologists and pulmonologists. Participants evaluated HRCTs from 203 suspected IPF patients, assigning a likelihood score for each of the guideline-based HRCT categories (each 0-100%, summing to 100%). SOFIA scores were then provided, and participants were given the opportunity to revise their scores. Agreement on (weighted kappa) and prognostic accuracy (Cox regression and C-index) of 1) UIP scores, 2) guideline-based diagnosis and 3) INBUILD categorisation (UIP/probable UIP vs indeterminate/alternative diagnosis – i.e., trial screening mode) were evaluated.

Results: 116 participants completed the study, including 20 ILD trained radiologists. The majority opinion of ILD radiologists on each HRCT was used as a diagnostic reference standard. SOFIA improved agreement for UIP probability scores among all participants, excluding the ILD radiologists, (0.67 [IQR 0.57-0.73] vs 0.71 [IQR, 0.65-0.76], p=2.1x10-5) and guideline-based diagnoses (0.50 [IQR 0.43-0.54] vs 0.61 [IQR, 0.56-0.66], p=2.8x10-16) and INBUILD categorisation (0.42 [IQR 0.35-0.47] vs 0.56 [IQR, 0.49-0.62], p=7.1x10-19). Prognostic accuracy for UIP probability scores (mortality) were good for radiologist scoring (n=116, C-index=0.60 [IQR 0.58-0.62]), and these improved with the addition of SOFIA (C-index=0.63 [IQR 0.61-0.65], p=3.6x10-12).

Conclusion: In pulmonary fibrosis, DL support may improve accuracy of HRCT diagnoses, provide prognostic information and faciliate screening in clinical trials.
Original languageEnglish
Article numberOA4848
JournalEuropean Respiratory Journal
Volume62
Issue numberSuppl 67
DOIs
Publication statusPublished online - 27 Oct 2023

Bibliographical note

This abstract was presented at the 2023 ERS International Congress, in session “Inflammatory endotyping: the macrophage across disease areas”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

Fingerprint

Dive into the research topics of 'Late Breaking Abstract - Artificial intelligence-based dec­­­ision support for HRCT stratification in fibrotic lung disease; an international study of 116 observers from 37 countries.'. Together they form a unique fingerprint.

Cite this